Navigation Links
Optima L-XP 60/50 Hz, 220-240 VAC

ProductsOptima L-XP 60/50 Hz, 220-240 VAC
Company Beckman Coulter, Inc.
Item Optima L-XP 60/50 Hz, 220-240 VAC
Features Advanced Optima eXPert software provides unprecedented centrifugation capabilities. It assists in developing the most efficient centrifugation methods, selecting the rotor and labware for a given application, then simulating the results before performing separations of proteins and sub-cellular particles. The innovative rotors built for the Optima L-XP are designed, manufactured and tested as a system from the inside out to get the highest quality of separation in the shortest possible time-safely and reliably. The increased efficiency of SW 32 Ti series rotors can reduce run times. The patented NVT rotors deliver the highest purity in the shortest possible time. Optima L-XP utilizes the most advanced materials and technology to achieve the high performance needed for extending the boundaries of research. And the imbalance-tolerant Optima L-XP drive safely accommodates tubes that are under- or over-filled by as much as 10%. The design of one-touch OptiSeal tubes delivers fast, reliable sealing--just insert the plug and press into place, and the centrifugation process itself provides guaranteed protection for samples.
Description Optima L-XP ultracentrifuge is designed to play a key role in the discovery process if research involves proteomics, cytomics or genomics. It has a sophisticated on-board computer, enhanced firmware, powerful Optima eXPert software and an easy-to-use touch screen, Optima L-XP delivers superior functionality, optimized user efficiencies, far greater capabilities and faster turnarounds than any other ultracentrifuge.
Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com

Related medicine products :

1. Optima Toric
2. Optima FW
3. Optima 38/SP
4. Optima L-XP 50 Hz, 220-240 VAC
5. Optima L-90 K Ultracentrifuge 50 Hz, 220-240 VAC
6. Optima L-90 K Ultracentrifuge 60/50 Hz, 220-240 VAC
7. Optima LE-80 K Ultracentrifuges 60/50 Hz, 220-240 VAC
8. Optima LE-80 K Ultracentrifuges 50 Hz, 220-240 VAC
9. OptimaMAX Ultracentrifuges 110 VAC 60 Hz
10. OptimaMAX-E Ultracentrifuges 110 VAC 60 Hz
11. Optima Stem
... has introduced the world's first minimally-invasive epicardial ... Epicardial Lead Implant Tool, which has been ... will expand the options available to implanting ... lead on the heart during pacemaker implants. ...
It is a cardio-pulmonary exercise testing device....
... The Series 2000 Treadmill is advanced ... performance. The extra-long, 60-inch treadmill surface ... for patients. The Series 2000 ... to accommodate severely debilitated patients. Its ...
... ECG Systems offer clinical features to meet ... functionality for paperless storage. Flexible, affordable, and ... PCE Exercise ECG software turns any computer ... with its ability to connect with leading ...
Medicine Products:
(Date:12/19/2014)... -- A new study suggests a possible link between ... and night sweats -- and higher rates of hip ... during menopause, affecting about 60 percent of women. The ... since they then face a higher risk of weakened ... exhibit moderate or severe menopausal symptoms are more likely ...
(Date:12/19/2014)... Dotinga HealthDay Reporter ... including ibuprofen, might slightly reduce your risk of developing ... of ibuprofen (Advil, Motrin) and naproxen (Aleve) appear to ... 15 percent, the researchers concluded after reviewing nine prior ... sun exposure. These painkillers "have potential ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, ... leg for at least 20 seconds you may be at ... on one leg may indicate that small strokes or tiny ... serious strokes is high, the investigators reported online Dec. 18 ... while standing on one leg, as well as problems walking, ...
(Date:12/17/2014)... Mass. (PRWEB) December 17, 2014 ... of Osteopathic Medicine (ACOM), which welcomed its inaugural ... Desktop Infrastructure (VDI) to seamlessly support bring your ... – and teaching – experience. The solution, comprised ... NetScaler , Dell server and storage infrastructure ...
(Date:12/17/2014)... December 17, 2014 A group of 127 ... Longevity, today, in reaction to a recent statement by the ... brain training and derogated the efficacy of all brain exercises. ... with the parts of the center’s statement critical of brain ... center had also overstated its case, in a document it ...
Breaking Medicine News(10 mins):Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4
... minister Andy Kerr has ordered the closure of two hospitals ... close the hospitals in the border as part of a ... the 80-year-old nine-bed Queen Margaret Hospital in Jedburgh and the ... worked hard to save the community hospitals. The Jedburgh Provost ...
... of laws was initiated by Quebec Health Minister Philippe Couillard ... health-care insurance //. ,The Supreme Court of Canada ... on June 9, 2005,ruling that Quebec had failed to prove ... medicare, was justified. However with the development of Bill ...
... fast-growing medical tourism industry is set to get a ... the entire range of medicare facilities overseas//. ,Global ... a leading travel firm, have signed an agreement to ... Africa, Canada and the Middle East. ...
... study has shed light on a different dimension to ... during childhood. // Insecure feelings experienced during childhood and ... of one’s body that can translate into an eating ... very early due to insecure attachment and separation anxiety. ...
... women, women overweight in their teens or later are at ... was conducted by scientists at the University of Pittsburgh Medical ... 2,110 women with and without ovarian cancer. The study of ... in recent years or at the age of 18, were ...
... boy’s divorced parents, whether to circumcise their son or not. ... inflammation in last year, his mother needs her son to be ... is fine and if circumcision was done it will result in ... 2003 divorce decree has given the rights to decide on the ...
Cached Medicine News:Health News:Quebecers To Choose Private Health-Care Insurance 2Health News:Plan to Promote the Medicare Facilities of India to Abroad 2
(Date:12/17/2014)... 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering, developing and commercializing innovative therapies addressing major ... of enrollment in its first Phase 2a study, ... confirmed the 1-month findings that were reported in ... - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/bf3b6l/electrocardiogram ) has ... - Global Trends, Estimates and Forecasts, 2012-2018" report ... Global Electrocardiogram Devices (ECG) sector is ... North America accounts for nearly 36% ... Europe claims approximately 27% (2018). ...
(Date:12/15/2014)... , Dec. 15, 2014  Inovio Pharmaceuticals, Inc. ... has been added to the NASDAQ Biotechnology Index ... will become effective upon market open on December ... is designed to track the performance of a ... either biotechnology or pharmaceutical according to the Industry ...
Breaking Medicine Technology:RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4